DOSAGE REGIMEN COMPRISING AP02L/TRAIL, ANTI-VEGF / ANTI-CD20 AND CHEMOTHERAPY TO TREAT NSCLC OR NON-HODGKIN'S LYMPHOMA, RESPECTIVELY
摘要
The invention provides methods of treating non-small cell lung cancer (NSCLC) and non-hodgkin's lymphoma (NHL). The methods include treating cancer cells with an effective amount of Apo2L/TRAIL and selected chemotherapy regimines and antibody therapies. Articles of manufacture and kits comprising Apo2L/TRAIL and package inserts that provide, eg, administration and dosing information for treating cancers such as NSCLC and NHL are also included.
申请公布号
WO2009140469(A3)
申请公布日期
2010.08.26
申请号
WO2009US43908
申请日期
2009.05.14
申请人
GENENTECH, INC.;AMGEN, INC.;IMMUNEX CORPORATION;NOVOTNY, WILLIAM;REESE, DAVID, MICHAEL;WYLD, PETER, JAMES
发明人
NOVOTNY, WILLIAM;REESE, DAVID, MICHAEL;WYLD, PETER, JAMES